Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients

Detalles Bibliográficos
Autores principales: Wambier, Carlos G., Nau, Gerard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Association of Urology. Published by Elsevier B.V. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864079/
https://www.ncbi.nlm.nih.gov/pubmed/35304000
http://dx.doi.org/10.1016/j.eururo.2022.01.049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864079/
https://www.ncbi.nlm.nih.gov/pubmed/35304000
http://dx.doi.org/10.1016/j.eururo.2022.01.049

Ejemplares similares